Literature DB >> 2582064

Failure of monoclonal antibodies to core glycolipid to bind intact smooth strains of Escherichia coli.

F Gigliotti, J L Shenep.   

Abstract

To study the ability of antibody to the core glycolipid (CGL) region of lipopolysaccharide (LPS) to bind intact gram-negative bacterial cells, we produced monoclonal antibodies that bind LPS from the Escherichia coli rough mutant J5. Four representative monoclonal antibodies that bound four distinct epitopes on the CGL region of LPS were studied. All four antibodies bound both isolated J5 LPS and intact J5 bacterial cells, but none of the antibodies bound to intact cells of E. coli O111:B4 or K1:O7. Binding of the monoclonal antibodies to isolated LPS from these latter two smooth strains was variable. These results confirm the presence of shared antigenic sites in the CGL region of heterologous LPS molecules but indicate that these sites are not necessarily available on smooth gram-negative bacteria for binding by antibody to CGL.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2582064     DOI: 10.1093/infdis/151.6.1005

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

Review 1.  Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.

Authors:  I G Mitov; D G Terziiski
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

2.  A murine monoclonal antibody specific for the outer core oligosaccharide of Salmonella lipopolysaccharide.

Authors:  R S Tsang; K H Chan; P Y Chau; K C Wan; M H Ng; S Schlecht
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

Review 3.  Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis.

Authors:  D L Dunn
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

4.  Antibiotic-induced bacterial cell lysis: a therapeutic dilemma.

Authors:  J L Shenep
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

5.  A direct enzyme-linked immunosorbent assay (ELISA) for antibodies to enterobacterial Re core glycolipid and lipid A. Results in healthy subjects and in patients infected by gram-negative bacteria.

Authors:  M Nys; P Damas; F Damas; L Joassin; J Demonty
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

6.  Characterization of anti-core glycolipid monoclonal antibodies with chemically defined lipopolysaccharides.

Authors:  J de Jongh-Leuvenink; J Schellekens; J Verhoef
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

7.  Outer membrane vesicles derived from Salmonella Typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model.

Authors:  Qiong Liu; Qing Liu; Jie Yi; Kang Liang; Tian Liu; Kenneth L Roland; Yanlong Jiang; Qingke Kong
Journal:  Int J Med Microbiol       Date:  2016-08-25       Impact factor: 3.473

8.  Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5.

Authors:  H Frasa; B Benaissa-Trouw; L Tavares; K van Kessel; W Hustinx; J Schellekens; K Kraaijeveld; J Verhoef
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

9.  A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides.

Authors:  F E Di Padova; H Brade; G R Barclay; I R Poxton; E Liehl; E Schuetze; H P Kocher; G Ramsay; M H Schreier; D B McClelland
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

10.  Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity.

Authors:  W C Bogard; D L Dunn; K Abernethy; C Kilgarriff; P C Kung
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.